EGFR and neoplasm: Consistent with these data, the abundance of phosphor-IWS1 and the U2AF2 E2/E3 ratio, correlates positively with tumor stage (Fig. 8c) and negatively with survival in patients with EGFR mutant, but not KRAS mutant tumors (Fig. 8d).